My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


SmofKabiven Central emulsion for infusion



Fresenius Kabi Deutschland GmbHPA2059/058/002

Main Information

Trade NameSmofKabiven Central emulsion for infusion
Active SubstancesSoya bean oil, refined
Medium chain triglycerides
Refined soyabean oil
Fish oil, rich in omega-3 acids
L-alanine
L-arginine
Glycine (aminoacetic acid)
L-histidine
L-isoleucine
L-leucine
L-lysine
L-methionine
L-phenylalanine
L-proline
L-serine
Taurine
L-threonine
L-tryptophan
L-tyrosine
L-valine
Calcium chloride
Sodium glycerophosphate
Magnesium sulfate
Potassium chloride
Sodium acetate
Zinc sulfate
Glucose
Dosage FormEmulsion for infusion
Licence HolderFresenius Kabi Deutschland GmbH
Licence NumberPA2059/058/002

Group Information

ATC CodeB05BA Solutions for parenteral nutrition
B05BA10 combinations

Status

License statusAuthorised
Licence Issued27/11/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print